---
layout: post
title: "Agency Information Collection Activities; Proposed Collection; Comment Request; General Drug Labeling Provisions and Over-the-Counter Monograph Drug User Fee Submissions"
date: 2026-02-05 19:00:39 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-19502
original_published: 2022-09-09 00:00:00 +0000
significance: 8.00
---

# Agency Information Collection Activities; Proposed Collection; Comment Request; General Drug Labeling Provisions and Over-the-Counter Monograph Drug User Fee Submissions

**Published:** February 05, 2026 19:00 UTC
**Source:** Federal Register
**Original Published:** September 09, 2022 00:00 UTC
**Document Number:** 2022-19502

## Summary

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed revision of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collections related to general drug product labeling and to over-the-counter (OTC) Monograph Drug User Fee (OMUFA) submissions.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/09/09/2022-19502/agency-information-collection-activities-proposed-collection-comment-request-general-drug-labeling)
- API: https://www.federalregister.gov/api/v1/documents/2022-19502

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
